Xiangxue Li

Qingdao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Exceptional response to chemo-immunotherapy in a patient with HER2-negative, TMB-high metastatic gastric mucinous adenocarcinoma: a case report and literature review.

Exceptional response to chemo-immunotherapy in a patient with HER2-negative, TMB-high metastatic gastric mucinous adenocarcinoma: a case report and literature review.

Journal: Frontiers in immunology

Published: September 25, 2025

Development and validation of a prognostic model for first-line immunotherapy for metastatic esophageal squamous cell carcinoma.

Development and validation of a prognostic model for first-line immunotherapy for metastatic esophageal squamous cell carcinoma.

Journal: International immunopharmacology

Published: September 16, 2025

Metachronous triple primary malignancies: a case report of NGS-guided multidisciplinary management and literature review.

Metachronous triple primary malignancies: a case report of NGS-guided multidisciplinary management and literature review.

Journal: Frontiers in oncology

Published: September 14, 2025

Development of a ferroptosis-related signature and identification of NOTCH2 as a novel prognostic biomarker in pancreatic cancer.

Development of a ferroptosis-related signature and identification of NOTCH2 as a novel prognostic biomarker in pancreatic cancer.

Journal: Frontiers in immunology

Published: July 04, 2025

Gastric Signet Ring Cell Carcinoma in a Helicobacter pylori-Positive 10-Year-Old Boy: A Case Report and Literature Review.

Gastric Signet Ring Cell Carcinoma in a Helicobacter pylori-Positive 10-Year-Old Boy: A Case Report and Literature Review.

Journal: Cancer science

Published: January 08, 2025

Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker.

Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker.

Journal: Human genomics

Published: August 14, 2024

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients.

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients.

Journal: Frontiers in immunology

Published: April 10, 2024

Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.

Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 04, 2024

Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.

Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.

Journal: Frontiers in immunology

Published: January 27, 2024

Showing 1-9 of 9

Last Updated: 09/26/2026